ST百灵(002424)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

002424 ST百灵

已收盘 09-30 15:00:00

{"stockData":{"symbol":"002424","market":"SZ","secType":"STK","nameCN":"ST百灵","latestPrice":4.69,"timestamp":1790751789000,"preClose":4.63,"halted":0,"volume":7182100,"delay":0,"changeRate":0.013,"floatShares":1140000000,"shares":1386000000,"eps":-0.0911,"marketStatus":"已收盘","change":0.06,"latestTime":"09-30 15:00:00","open":4.61,"high":4.72,"low":4.61,"amount":33534100,"amplitude":0.0238,"askPrice":4.69,"askSize":2641,"bidPrice":4.68,"bidSize":443,"shortable":0,"etf":0,"ttmEps":-0.0911,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791423000000},"marketStatusCode":5,"adr":0,"adjPreClose":4.63,"symbolType":"stock","openAndCloseTimeList":[[1790731800000,1790739000000],[1790744400000,1790751600000]],"highLimit":4.86,"lowLimit":4.4,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":1385501500,"isCdr":false,"pbRate":2.01,"roa":"--","roe":"0.95%","epsLYR":-0.08,"committee":-0.213675,"marketValue":6498000000,"turnoverRate":0.0063,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-10-08。","floatMarketCap":5346000000},"requestUrl":"/m/hq/s/002424/wiki","defaultTab":"wiki","newsList":[{"id":"2671429194","title":"ST百灵（002424）9月29日主力资金净买入59.38万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671429194","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671429194?lang=zh_cn&edition=full","pubTime":"2026-09-29 15:36","pubTimestamp":1790667389,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月29日收盘，ST百灵报收于4.63元，下跌1.7%，换手率0.87%，成交量9.87万手，成交额4624.96万元。9月29日的资金流向数据方面，主力资金净流入59.38万元，占总成交额1.28%，游资资金净流出5.28万元，占总成交额0.11%，散户资金净流出54.1万元，占总成交额1.17%。ST百灵主营业务：集苗药研发、生产、销售于一体的医药上市公司。当天两者的差额即是当天两种力量相抵之后剩下的推动股价上升的净力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900020588.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002424","BK0183","BK0028","BK0146","BK0239","BK0077","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670235608","title":"ST百灵(002424)9月10日股东户数5.8万户，较上期减少0.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2670235608","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670235608?lang=zh_cn&edition=full","pubTime":"2026-09-28 17:50","pubTimestamp":1790589041,"startTime":"0","endTime":"0","summary":"证券之星消息，近日ST百灵披露，截至2026年9月10日公司股东户数为5.8万户，较8月10日减少471.0户，减幅为0.81%。在中药行业个股中，ST百灵股东户数高于行业平均水平，截至9月10日，中药行业平均股东户数为5.22万户。从股价来看，2026年8月10日至2026年9月10日，ST百灵区间涨幅为0.65%，在此期间股东户数减少471.0户，减幅为0.81%。根据统计，ST百灵2026年8月10日至2026年9月10日，主力资金净流出5058.73万元，游资资金净流入2343.59万元，散户资金净流入2715.14万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800023378.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0077","BK0146","BK0183","002424","BK0028","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670282802","title":"ST百灵（002424）9月28日主力资金净买入132.44万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2670282802","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670282802?lang=zh_cn&edition=full","pubTime":"2026-09-28 15:29","pubTimestamp":1790580557,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月28日收盘，ST百灵报收于4.71元，上涨2.17%，换手率1.05%，成交量12.0万手，成交额5556.39万元。9月28日的资金流向数据方面，主力资金净流入132.44万元，占总成交额2.38%，游资资金净流出190.65万元，占总成交额3.43%，散户资金净流入58.21万元，占总成交额1.05%。ST百灵主营业务：集苗药研发、生产、销售于一体的医药上市公司。当天两者的差额即是当天两种力量相抵之后剩下的推动股价上升的净力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800014597.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","002424","BK0239","BK0028","BK0188","BK0077","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670409782","title":"股市必读：ST百灵新发布《关于获得发明专利证书的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2670409782","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670409782?lang=zh_cn&edition=full","pubTime":"2026-09-28 02:23","pubTimestamp":1790533391,"startTime":"0","endTime":"0","summary":"截至2026年9月24日收盘，ST百灵报收于4.61元，上涨3.83%，换手率1.96%，成交量22.39万手，成交额1.04亿元。当日关注点交易信息汇总：9月24日主力资金净流入504.7万元，占总成交额4.85%。公司公告汇总：ST百灵于9月23日公告获得发明专利证书，专利名称为“一种治疗糖尿病或其并发症的中药制剂”，专利号ZL202610042695.2，授权公告日为2026年9月18日。该专利为保密发明专利，技术内容未予公开。专利权人为贵州百灵企业集团制药股份有限公司，发明人为姜伟。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800001215.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002424","BK0146","BK0183","BK0077","BK0239","BK0028","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669810450","title":"ST百灵（002424）9月24日主力资金净买入504.70万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2669810450","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669810450?lang=zh_cn&edition=full","pubTime":"2026-09-24 15:29","pubTimestamp":1790234956,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月24日收盘，ST百灵报收于4.61元，上涨3.83%，换手率1.96%，成交量22.39万手，成交额1.04亿元。9月24日的资金流向数据方面，主力资金净流入504.7万元，占总成交额4.85%，游资资金净流入44.62万元，占总成交额0.43%，散户资金净流出549.32万元，占总成交额5.28%。ST百灵主营业务：集苗药研发、生产、销售于一体的医药上市公司。当天两者的差额即是当天两种力量相抵之后剩下的推动股价上升的净力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400021648.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002424","BK0188","BK0077","BK0239","BK0146","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669438989","title":"股市必读：ST百灵新发布《关于获得发明专利证书的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2669438989","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669438989?lang=zh_cn&edition=full","pubTime":"2026-09-24 01:22","pubTimestamp":1790184132,"startTime":"0","endTime":"0","summary":"截至2026年9月23日收盘，ST百灵报收于4.44元，下跌1.77%，换手率0.7%，成交量7.99万手，成交额3571.43万元。当日关注点交易信息汇总：9月23日主力资金净流出1118.69万元，占总成交额31.33%。公司公告汇总：ST百灵于9月23日公告获得发明专利证书，专利名称为“一种治疗糖尿病或其并发症的中药制剂”，专利号ZL202610042695.2，授权公告日为2026年9月18日。该专利为保密发明专利，技术内容未予公开。专利权人为贵州百灵企业集团制药股份有限公司，发明人为姜伟。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400001996.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","002424","BK0183","BK0239","BK0077","BK0146","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668252199","title":"ST百灵：关于黄连解毒丸项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2668252199","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668252199?lang=zh_cn&edition=full","pubTime":"2026-09-18 20:48","pubTimestamp":1789735710,"startTime":"0","endTime":"0","summary":"那个子公司和仁堂20%股份购买后十年不过户，重组人内皮抑素注射液项目纠纷也多年未解决，黄连解毒丸项目3期临床结束都2年多了还没看到上市申请…谢谢ST百灵回复：感谢您对公司长期关注以及所提的宝贵建议，公司已收悉并将转相关部门。公司将持续关注并依法依规推进该事项的后续办理工作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091800034938.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","002424","BK0183","BK0028","BK0188","BK0239","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668252919","title":"ST百灵：截止2026年9月10日，公司股东总户数为58,013","url":"https://stock-news.laohu8.com/highlight/detail?id=2668252919","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668252919?lang=zh_cn&edition=full","pubTime":"2026-09-18 20:48","pubTimestamp":1789735705,"startTime":"0","endTime":"0","summary":"证券之星消息，ST百灵(002424)09月18日在投资者关系平台上答复投资者关心的问题。投资者提问：股东人数多少？ST百灵回复：感谢您对公司的关注。截止2026年9月10日，公司股东总户数为58,013。谢谢。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091800034932.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0188","BK0183","BK0146","002424","BK0077","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667615619","title":"“贵州前首富”花式侵蚀贵州百灵","url":"https://stock-news.laohu8.com/highlight/detail?id=2667615619","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667615619?lang=zh_cn&edition=full","pubTime":"2026-09-15 12:29","pubTimestamp":1789446551,"startTime":"0","endTime":"0","summary":"2024年4月15日至18日，姜伟决策禹慧进取3号证券账户卖出贵州百灵股票1425万股，卖出金额约9656.35万元。今年3月，贵州证监局查实，贵州百灵2019年-2023年年度报告，均存在虚假记载。因为上述财务造假行为，贵州百灵及9名涉事董监高被处以行政处罚。2017年，姜伟家族以165亿元财富，登上“贵州首富”的宝座。经追溯调整，2019年和2020年，贵州百灵连续两年归母净利润亏损。截至目前，姜伟直接持有贵州百灵17.55%股权，仍为控股股东和实际控制人。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1789087597512983265","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["002424","BK0146","BK0188","BK0183","BK0239","BK0028","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667631189","title":"违规“抢跑”避损1.5亿，贵州百灵实控人被罚没超3亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2667631189","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667631189?lang=zh_cn&edition=full","pubTime":"2026-09-14 10:00","pubTimestamp":1789351200,"startTime":"0","endTime":"0","summary":"公告称，姜伟涉嫌内幕交易公司股票及相关场外衍生品合约、涉嫌信息披露违法、违反限制性规定转让股票一案，已调查完毕，证监会拟对其个人合计罚没超3亿元，并采取5年证券市场禁入措施。彼时，贵州百灵因2019年至2023年连续五年财务造假、信息披露严重违规，被贵州证监局罚款1000万元。姜伟作为公司董事长、实控人，被罚款500万元，并处10年证券市场禁入措施。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/companyt/2026-09-14/doc-iniruarh4115035.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0183","002424","BK0188","BK0077","BK0239","BK0028","BK0146"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666233545","title":"“贵州前首富”花式侵蚀贵州百灵","url":"https://stock-news.laohu8.com/highlight/detail?id=2666233545","media":"斑马消费","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666233545?lang=zh_cn&edition=full","pubTime":"2026-09-11 07:39","pubTimestamp":1789083540,"startTime":"0","endTime":"0","summary":"姜伟一手打造的“苗药第一股”贵州百灵，却在他的不断侵蚀下，渐渐失去往日的光彩。今年3月，贵州证监局查实，贵州百灵2019年-2023年年度报告，均存在虚假记载。因为上述财务造假行为，贵州百灵及9名涉事董监高被处以行政处罚。2017年，姜伟家族以165亿元财富，登上“贵州首富”的宝座。经追溯调整，2019年和2020年，贵州百灵连续两年归母净利润亏损。截至目前，姜伟直接持有贵州百灵17.55%股权，仍为控股股东和实际控制人。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzI0MDY2ODM2MQ==&mid=2247524879&idx=1&sn=8876eb0e31acce6171707e14feafef93&chksm=e89169d1ea9b5d88c338862b2e5fd4fbf6f068ec33bb2e568a5d41ee8b92c5b2041519622f21&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["BK0146","002424","BK0239","BK0028","BK0077","BK0188","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666959590","title":"股市必读：ST百灵新发布《关于实际控制人收到《行政处罚事先告知书》的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2666959590","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666959590?lang=zh_cn&edition=full","pubTime":"2026-09-11 02:00","pubTimestamp":1789063247,"startTime":"0","endTime":"0","summary":"公司公告汇总关于实际控制人收到《行政处罚事先告知书》的公告贵州百灵实际控制人姜伟收到中国证监会《行政处罚事先告知书》，因涉嫌内幕交易、信息披露违法及违反限制性规定转让股票。中国证监会拟对姜伟没收违法所得并处罚款，合计约3.12亿元，并采取5年证券市场禁入措施。顾自力协助内幕交易，被处以相应罚款。本次回购股份注销事宜已于2026年9月8日经中国证券登记结算有限责任公司深圳分公司审核确认生效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100002512.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0028","BK0183","BK0188","BK0239","BK0146","002424"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666531972","title":"ST百灵最新公告：实控人姜伟收到行政处罚事先告知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2666531972","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666531972?lang=zh_cn&edition=full","pubTime":"2026-09-09 23:40","pubTimestamp":1788968427,"startTime":"0","endTime":"0","summary":"ST百灵(002424.SZ)公告称，公司实际控制人姜伟收到证监会《行政处罚事先告知书》。证监会拟对姜伟、顾自力内幕交易贵州百灵股票及相关场外衍生品合约、姜伟信息披露违法及违反限制性规定转让股票等行为作出处罚。其中，拟没收姜伟、顾自力内幕交易股票违法所得2971万元并处罚款，没收衍生品合约违法所得1.26亿元并处罚款，另对姜伟信息披露违法及违规转让股票各罚款100万元。同时，拟对姜伟采取5年证券市场禁入措施。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090900039256.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0183","BK0239","BK0146","002424","BK0077","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664845395","title":"股市必读：ST百灵新发布《关于第六届董事会第三十次会议决议的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664845395","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664845395?lang=zh_cn&edition=full","pubTime":"2026-09-03 01:47","pubTimestamp":1788371230,"startTime":"0","endTime":"0","summary":"公司公告汇总关于第六届董事会第三十次会议决议的公告贵州百灵企业集团制药股份有限公司于2026年9月2日召开第六届董事会第三十次会议，审议通过《关于修订〈公司章程〉的议案》《关于修订〈董事会议事规则〉的议案》《关于修订〈董事会秘书工作制度〉的议案》及《关于召开2026年第五次临时股东会的议案》。本次修订涉及董事会成员构成，独立董事由4名调整为3名，增设1名职工代表董事，并完善董事会秘书职责条款。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300001789.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0188","BK0183","BK0146","002424","BK0077","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664008817","title":"ST百灵（002424）披露召开2026年第五次临时股东会通知，9月2日股价下跌1.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664008817","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664008817?lang=zh_cn&edition=full","pubTime":"2026-09-02 22:37","pubTimestamp":1788359832,"startTime":"0","endTime":"0","summary":"截至2026年9月2日收盘，ST百灵报收于4.6元，较前一交易日下跌1.5%，最新总市值为64.29亿元。该股当日开盘4.68元，最高4.68元，最低4.6元，成交额达3092.34万元，换手率为0.58%。近日，ST百灵披露《关于召开2026年第五次临时股东会通知的公告》。公告显示，公司将于2026年09月18日召开2026年第五次临时股东会，会议由董事会召集，现场会议时间为当日14:00，网络投票时间为同日上午9:15至下午15:00。股权登记日为2026年09月11日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200043116.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0146","BK0077","BK0183","002424","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664888583","title":"股市必读：ST百灵新发布《关于全资子公司获得药物临床试验批准通知书的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664888583","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664888583?lang=zh_cn&edition=full","pubTime":"2026-09-01 03:44","pubTimestamp":1788205454,"startTime":"0","endTime":"0","summary":"公司公告汇总：全资子公司百灵毓秀（珠海）医药有限公司收到国家药监局签发的《药物临床试验批准通知书》，创新药吸入用BD77获批开展慢性阻塞性肺病临床试验。吸入用BD77是来源于单一法定中药材的小分子化学药，纯度超过98%，已开展药理学与药效学研究，显示其在多种病原体引起的肺炎模型中具有治疗作用。目前该药尚处于临床试验获批阶段，后续仍需开展临床试验并经审批方可上市，存在研发风险及不确定性，对公司近期业绩无重大影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100004155.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002424","BK0183","BK0028","BK0077","BK0146","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662930203","title":"图解ST百灵中报：第二季度单季净利润同比下降93.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662930203","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662930203?lang=zh_cn&edition=full","pubTime":"2026-08-25 02:23","pubTimestamp":1787595836,"startTime":"0","endTime":"0","summary":"证券之星消息，ST百灵2026年中报显示，上半年度公司主营收入9.7亿元，同比下降33.62%；归母净利润3002.79万元，同比下降42.07%；扣非净利润2769.23万元，同比上升100.01%；其中2026年第二季度，公司单季度主营收入3.26亿元，同比下降53.47%；单季度归母净利润183.83万元，同比下降93.36%；单季度扣非净利润-98.76万元，同比下降108.06%；负债率43.95%，投资收益-2795.65万元，财务费用2583.2万元，毛利率41.78%。财报数据概要请见下图:本文数据来源于ST百灵2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500005366.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002424"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653572066","title":"股市必读：ST百灵（002424）7月23日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2653572066","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653572066?lang=zh_cn&edition=full","pubTime":"2026-07-24 02:28","pubTimestamp":1784831293,"startTime":"0","endTime":"0","summary":"截至2026年7月23日收盘，ST百灵报收于4.46元，上涨1.13%，换手率0.44%，成交量5.09万手，成交额2257.13万元。董秘最新回复投资者： 董秘你好，截至今天为止股东人数是多少？董秘： 感谢您对公司的关注，截止2026年7月20日，公司股东总户数为58,908。当日关注点交易信息汇总：7月23日主力资金净流入84.43万元，占总成交额0.0%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072400001677.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0183","BK0239","002424","BK0146","BK0077","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653728444","title":"ST百灵：截止2026年7月20日股东总户数为58,908","url":"https://stock-news.laohu8.com/highlight/detail?id=2653728444","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653728444?lang=zh_cn&edition=full","pubTime":"2026-07-23 20:58","pubTimestamp":1784811490,"startTime":"0","endTime":"0","summary":"证券之星消息，ST百灵(002424)07月23日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好，截至今天为止股东人数是多少？ST百灵回复：感谢您对公司的关注，截止2026年7月20日，公司股东总户数为58,908。谢谢。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072300045796.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002424","BK0239","BK0188","BK0146","BK0077","BK0183","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650350131","title":"ST百灵（002424）披露公司产品纳入《国家基本药物目录（2026年版）》的公告，7月10日股价上涨1.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2650350131","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650350131?lang=zh_cn&edition=full","pubTime":"2026-07-10 22:31","pubTimestamp":1783693870,"startTime":"0","endTime":"0","summary":"截至2026年7月10日收盘，ST百灵报收于4.51元，较前一交易日上涨1.58%，最新总市值为63.03亿元。该股当日开盘4.43元，最高4.55元，最低4.39元，成交额达4169.02万元，换手率为0.81%。近日，ST百灵披露《关于公司产品纳入〈国家基本药物目录〉的公告》。公告显示，国家卫生健康委员会于2026年7月9日发布《国家基本药物目录》，自2026年9月1日起施行。其中银丹心脑通软胶囊为公司核心独家产品，系首家中药二级保护品种和《中国药典》首批收载的苗药品种。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000044662.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002424","BK0239","BK0028","BK0183","BK0146","BK0188","BK0077"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1790979520363,"stockEarnings":[{"period":"1week","weight":0.0563},{"period":"1month","weight":0.0196},{"period":"3month","weight":0.0353},{"period":"6month","weight":-0.0563},{"period":"1year","weight":-0.1067},{"period":"ytd","weight":0.0782}],"compareEarnings":[{"period":"1week","weight":-0.024},{"period":"1month","weight":-0.0362},{"period":"3month","weight":-0.0463},{"period":"6month","weight":-0.0098},{"period":"1year","weight":-0.0105},{"period":"ytd","weight":-0.0319}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"贵州百灵企业集团制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"58013人(较上一季度减少0.44%)","perCapita":"19646股","listingDate":"2010-06-03","address":"贵州省安顺市西秀区经济技术开发区西航路212号","registeredCapital":"138550万元","survey":"　　贵州百灵企业集团制药股份有限公司的主营业务是苗药研发、生产、销售。公司的主要产品是银丹心脑通软胶囊、咳速停糖浆/胶囊、复方一枝黄花喷雾剂、维C银翘片、小儿柴桂退热颗粒、强力枇杷露、双羊喉痹通颗粒。公司获得了贵州省医药产业骨干企业、全国最大的苗药研制生产企业、2025中国医药市场药企排行榜（中药）TOP100第28位、2026中药研发实力TOP50榜单、第二届“长高赛”最佳商业化潜力奖。","listedPrice":40},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ST百灵(002424)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ST百灵(002424)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ST百灵,002424,ST百灵股票,ST百灵股票老虎,ST百灵股票老虎国际,ST百灵行情,ST百灵股票行情,ST百灵股价,ST百灵股市,ST百灵股票价格,ST百灵股票交易,ST百灵股票购买,ST百灵股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ST百灵(002424)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ST百灵(002424)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}